D John Bennett, | |
325 W Center Street, Spanish Fork, UT 84660 | |
(801) 798-7301 | |
(801) 798-8513 |
Full Name | D John Bennett |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 325 W Center Street, Spanish Fork, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508968777 | NPI | - | NPPES |
D0463 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 187592-1205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
D John Bennett, 325 W Center Street, Spanish Fork, UT 84660 Ph: (801) 798-7301 | D John Bennett, 325 W Center Street, Spanish Fork, UT 84660 Ph: (801) 798-7301 |
News Archive
Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists who met at the NIH State of the Science Symposium in Therapeutic Apheresis. Nora Ratcliffe, MD, of Dartmouth Hitchcock, looked at current methodology and opportunities for research in a paper recently published in Transfusion Medicine Review, titled "National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis."
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.
Eli Lilly and Company and Bristol-Myers Squibb Company announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).
A new injection device for the endoscopic treatment of vesicoureteral reflux) offers urologists greater control, precision and accuracy for treating a condition of the urinary tract that predominantly affects infants and young children. An alternative to corrective surgery, the Injekt VUR Injection Needle marks an advancement in fast and minimally-invasive endoscopic treatment.
› Verified 2 days ago
Dr. Patrick Tanner Mcvey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 325 West Center, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Scott Stroshine, D.O Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 E 700 N, Spanish Fork, UT 84660 Phone: 801-794-7947 Fax: 801-794-7949 | |
Sarah Ngocvi Tang, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 325 W Center St, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 | |
Richard D Paxton, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 325 W Center St, Spanish Fork, UT 84660 Phone: 801-798-7301 Fax: 801-798-8513 |